These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 39067788)
21. Outcomes of haploidentical peripheral stem cell transplantation with combination of post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG) compared to unrelated donor transplantation in acute myeloid leukemia: A retrospective 10-year experience. Barkhordar M; Kasaeian A; Janbabai G; Mousavi SA; Fumani HK; Tavakoli S; Bahri T; Ghavamzadeh A; Vaezi M Leuk Res; 2022 Sep; 120():106918. PubMed ID: 35843087 [TBL] [Abstract][Full Text] [Related]
22. Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia. Lu Y; Sun RJ; Zhao YL; Xiong M; Cao XY; Zhang JP; Wei ZJ; Zhou JR; Liu DY; Lu DP Biol Blood Marrow Transplant; 2018 Sep; 24(9):1881-1887. PubMed ID: 29772350 [TBL] [Abstract][Full Text] [Related]
23. Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT. Sanz J; Galimard JE; Labopin M; Afanasyev B; Angelucci E; Ciceri F; Blaise D; Cornelissen JJ; Meijer E; Diez-Martin JL; Koc Y; Rovira M; Castagna L; Savani B; Ruggeri A; Nagler A; Mohty M; J Hematol Oncol; 2020 May; 13(1):46. PubMed ID: 32375860 [TBL] [Abstract][Full Text] [Related]
24. Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Tsai SB; Rhodes J; Liu H; Shore T; Bishop M; Cushing MM; Gergis U; Godley L; Kline J; Larson RA; Mayer S; Odenike O; Stock W; Wickrema A; van Besien K; Artz AS Biol Blood Marrow Transplant; 2018 May; 24(5):997-1004. PubMed ID: 29288821 [TBL] [Abstract][Full Text] [Related]
25. Haploidentical transplantation in pediatric non-malignant diseases: A retrospective analysis on behalf of the Spanish Group for Hematopoietic Transplantation (GETH). Torres Canizales J; Ferreras C; Pascual A; Alonso L; Regueiro A; Plaza M; Pérez Hurtado JM; Benito A; Couselo JM; Fuster JL; Díaz-Almirón M; Bueno D; Mozo Y; Gómez López A; Vicario JL; Balas A; Sisinni L; Díaz de Heredia C; Pérez-Martínez A Eur J Haematol; 2021 Feb; 106(2):196-204. PubMed ID: 33084101 [TBL] [Abstract][Full Text] [Related]
26. Characterization of Chronic Graft-versus-host Disease After Haploidentical Stem Cell Transplantation With Posttransplant Cyclophosphamide: A Study on Behalf of GETH-TC. Fonseca-Santos M; Bailen R; Lopez-Godino O; Herruzo-Delgado B; Bermudez MA; García-Cadenas I; Huguet-Mas M; Ferra-Coll C; Esquirol A; Cortés-Rodriguez M; Yañez-Sansegundo L; Pascual-Cascon MJ; Heras I; Kwon M; Lopez-Corral L; Transplantation; 2024 Oct; 108(10):2134-2143. PubMed ID: 38685204 [TBL] [Abstract][Full Text] [Related]
27. Dynamic immune profiling identifies the stronger graft-versus-leukemia (GVL) effects with haploidentical allografts compared to HLA-matched stem cell transplantation. Guo H; Chang YJ; Hong Y; Xu LP; Wang Y; Zhang XH; Wang M; Chen H; Chen YH; Wang FR; Wei-Han ; Sun YQ; Yan CH; Tang FF; Mo XD; Liu KY; Huang XJ Cell Mol Immunol; 2021 May; 18(5):1172-1185. PubMed ID: 33408344 [TBL] [Abstract][Full Text] [Related]
28. Outcome of haploidentical versus matched sibling donors in hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation. Nagler A; Labopin M; Houhou M; Aljurf M; Mousavi A; Hamladji RM; Al Zahrani M; Bondarenko S; Arat M; Angelucci E; Koc Y; Gülbas Z; Sica S; Bourhis JH; Canaani J; Brissot E; Giebel S; Mohty M J Hematol Oncol; 2021 Apr; 14(1):53. PubMed ID: 33794963 [TBL] [Abstract][Full Text] [Related]
29. Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH). Pérez-Martínez A; Ferreras C; Pascual A; Gonzalez-Vicent M; Alonso L; Badell I; Fernández Navarro JM; Regueiro A; Plaza M; Pérez Hurtado JM; Benito A; Beléndez C; Couselo JM; Fuster JL; Díaz-Almirón M; Bueno D; Mozo Y; Marsal J; Gómez López A; Sisinni L; de Heredia CD; Díaz MÁ Am J Hematol; 2020 Jan; 95(1):28-37. PubMed ID: 31625177 [TBL] [Abstract][Full Text] [Related]
30. Comparison of outcomes after umbilical cord blood and unmanipulated haploidentical hematopoietic stem cell transplantation in children with high-risk acute lymphoblastic leukemia. Mo XD; Tang BL; Zhang XH; Zheng CC; Xu LP; Zhu XY; Wang Y; Liu HL; Yan CH; Chu XD; Chen H; Geng LQ; Liu KY; Sun ZM; Huang XJ Int J Cancer; 2016 Nov; 139(9):2106-15. PubMed ID: 27356906 [TBL] [Abstract][Full Text] [Related]
31. Clinical Outcomes of B Cell Acute Lymphoblastic Leukemia Patients Treated with Haploidentical Stem Cells Combined with Umbilical Cord Blood Transplantation. Zhou B; Xu M; Lu S; Liu Y; Qi L; Liu T; Tian H; Chen J; Wu D; Xu Y Transplant Cell Ther; 2022 Mar; 28(3):173.e1-173.e6. PubMed ID: 34954150 [TBL] [Abstract][Full Text] [Related]
32. Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study. Matsuda K; Konuma T; Fuse K; Masuko M; Kawamura K; Hirayama M; Uchida N; Ikegame K; Wake A; Eto T; Doki N; Miyakoshi S; Tanaka M; Takahashi S; Onizuka M; Kato K; Kimura T; Ichinohe T; Takayama N; Kobayashi H; Nakamae H; Atsuta Y; Kanda J; Yanada M Br J Haematol; 2023 Apr; 201(1):106-113. PubMed ID: 36281887 [TBL] [Abstract][Full Text] [Related]
33. T-cell-depleted haploidentical stem cell transplantation results improve with time in adults with acute leukemia: A study from the Acute Leukemia Working Party of the European Society of Blood and Marrow Transplantation (EBMT). Sestili S; Labopin M; Ruggeri A; Velardi A; Ciceri F; Maertens J; Kanz L; Aversa F; Lewalle P; Bunjes D; Mohty M; Nagler A Cancer; 2018 May; 124(10):2142-2150. PubMed ID: 29469924 [TBL] [Abstract][Full Text] [Related]
34. Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. Santoro N; Ruggeri A; Labopin M; Bacigalupo A; Ciceri F; Gülbaş Z; Huang H; Afanasyev B; Arcese W; Wu D; Koc Y; Tischer J; Santarone S; Giebel S; Mohty M; Nagler A J Hematol Oncol; 2017 May; 10(1):113. PubMed ID: 28558762 [TBL] [Abstract][Full Text] [Related]
35. Stem cell transplantation from a haploidentical donor versus a genoidentical sister for adult male patients with acute myelogenous leukemia in first remission: A retrospective study from the acute leukemia working party of the European Society for Blood and Marrow Transplantation. Gorin NC; Labopin M; Blaise D; de Groot M; Socié G; Bourhis JH; Ciceri F; Polge E; Nagler A; Mohty M Cancer; 2020 Mar; 126(5):1004-1015. PubMed ID: 31774557 [TBL] [Abstract][Full Text] [Related]
36. Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients. Pagliardini T; Castagna L; Harbi S; Porta MD; Rey J; Fürst S; Bramanti S; Saillard C; Legrand F; Maisano V; Faucher C; Granata A; Hospital MA; Lining W; Weiller PJ; Calmels B; Charbonnier A; Lemarie C; Chabannon C; Vey N; Mokart D; Blaise D; Devillier R Biol Blood Marrow Transplant; 2019 Sep; 25(9):1803-1809. PubMed ID: 31128325 [TBL] [Abstract][Full Text] [Related]
37. Combined haploidentical and cord blood transplantation for refractory severe aplastic anaemia and hypoplastic myelodysplastic syndrome. Childs RW; Tian X; Vo P; Purev E; Kotecha RR; Carlsten M; Clara J; Flegel WA; Adams SD; Khuu HM; Stroncek DF; Cook L; Worthy T; Geller NL; Wells B; Wilder J; Reger R; Aue G Br J Haematol; 2021 Jun; 193(5):951-960. PubMed ID: 33993466 [TBL] [Abstract][Full Text] [Related]
38. Allogeneic hematopoietic transplantation using haploidentical donor vs. unrelated cord blood donor in pediatric patients: a single-center retrospective study. González-Vicent M; Molina B; Andión M; Sevilla J; Ramirez M; Pérez A; Díaz MA Eur J Haematol; 2011 Jul; 87(1):46-53. PubMed ID: 21692851 [TBL] [Abstract][Full Text] [Related]
39. Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients with Intermediate-risk Acute Myelogenous Leukemia in First Complete Remission. Lv M; Wang Y; Chang YJ; Zhang XH; Xu LP; Jiang Q; Jiang H; Lu J; Chen H; Han W; Wang FR; Wang JZ; Chen Y; Yan CH; Zhang YY; Sun YQ; Mo XD; Zhu HH; Jia JS; Zhao T; Wang J; Liu KY; Huang XJ Clin Cancer Res; 2019 Mar; 25(6):1737-1748. PubMed ID: 30478089 [TBL] [Abstract][Full Text] [Related]
40. HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties. Giardino S; Eikema DJ; Piepenbroek B; Algeri M; Ayas M; Faraci M; Tbakhi A; Zecca M; Essa M; Neven B; Bertrand Y; Kharya G; Bykova T; Lawson S; Petrini M; Mohseny A; Rialland F; James B; Colita A; Fahd M; Cesaro S; Schulz A; Kleinschmidt K; Kałwak K; Corbacioglu S; Dufour C; Risitano A; de Latour RP Am J Hematol; 2024 Jun; 99(6):1066-1076. PubMed ID: 38497679 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]